rts logo

ELAN Stock Forecast: All the More Reason to Consider Elanco Animal Health Inc (ELAN) Now

MQ Stock

Elanco Animal Health Inc (NYSE: ELAN) is 4.56% higher on its value in year-to-date trading and has touched a low of $7.88 and a high of $16.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ELAN stock was last observed hovering at around $15.97 in the last trading session, with the day’s loss setting it -0.39%.

Currently trading at $15.58, the stock is -2.66% and -1.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.47 million and changing -2.44% at the moment leaves the stock 22.90% off its SMA200. ELAN registered 71.40% gain for a year compared to 6-month gain of 38.61%. The firm has a 50-day simple moving average (SMA 50) of $2.97 and a 200-day simple moving average (SMA200) of -$58.49.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a -2.81% loss in the last 1 month and extending the period to 3 months gives it a 4.56%, and is -2.07% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.92% over the week and 2.48% over the month.

Elanco Animal Health Inc (ELAN) has around 9800 employees, a market worth around $7.68B and $4.42B in sales. Fwd P/E is 14.68. Profit margin for the company is -27.87%. Distance from 52-week low is 97.72% and -7.70% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.20%).

Elanco Animal Health Inc quarterly earnings per share for the current quarter are estimated at $0.26 with sales reaching $1.17B over the same period.The EPS is expected to grow by 3.61% this year, but quarterly earnings will post 1.80% year-over-year. Quarterly sales are estimated to shrink -6.50% in year-over-year returns.

Elanco Animal Health Inc (ELAN) Top Institutional Holders

496 institutions hold shares in Elanco Animal Health Inc (ELAN), with institutional investors hold 99.85% of the company’s shares. The shares outstanding are 492.85M, and float is at 488.14M with Short Float at 2.66%. Institutions hold 99.20% of the Float.

The top institutional shareholder in the company is Dodge & Cox Inc with over 84.62 million shares valued at $851.29 million. The investor’s holdings represent 17.18% of the ELAN Shares outstanding. As of Jun 29, 2023, the second largest holder is Primecap Management Company with 49.0 million shares valued at $492.9 million to account for 9.94% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 48.64 million shares representing 9.87% and valued at over $489.31 million, while Blackrock Inc. holds 5.51% of the shares totaling 27.16 million with a market value of $273.19 million.

Elanco Animal Health Inc (ELAN) Insider Activity

The most recent transaction is an insider purchase by DOYLE WILLIAM F,the company’sDirector. SEC filings show that DOYLE WILLIAM F bought 15,000 shares of the company’s common stock on Mar 08 ’24 at a price of $16.30 per share for a total of $0.24 million. Following the purchase, the insider now owns 61330.0 shares.

Elanco Animal Health Inc disclosed in a document filed with the SEC on Mar 08 ’24 that Harrington Michael J (Director) bought a total of 3,100 shares of the company’s common stock. The trade occurred on Mar 08 ’24 and was made at $16.29 per share for $50494.0. Following the transaction, the insider now directly holds 77594.0 shares of the ELAN stock.

Still, SEC filings show that on Mar 06 ’24, HOOVER R DAVID (Director) acquired 20,000 shares at an average price of $16.14 for $0.32 million. The insider now directly holds 185,000 shares of Elanco Animal Health Inc (ELAN).

Related Posts